- Home
- AMLX vs ZSPC Comparison
AMLX vs ZSPC Comparison
Compare AMLX & ZSPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- ZSPC
- Stock Information
- Founded
- AMLX 2014
- ZSPC 2007
- Country
- AMLX United States
- ZSPC United States
- Employees
- AMLX N/A
- ZSPC N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- ZSPC
- Sector
- AMLX Health Care
- ZSPC
- Exchange
- AMLX Nasdaq
- ZSPC NYSE
- Market Cap
- AMLX 330.5M
- ZSPC 340.9M
- IPO Year
- AMLX 2022
- ZSPC 2024
- Fundamental
- Price
- AMLX $3.56
- ZSPC $7.99
- Analyst Decision
- AMLX Buy
- ZSPC Strong Buy
- Analyst Count
- AMLX 4
- ZSPC 3
- Target Price
- AMLX $7.50
- ZSPC $13.67
- AVG Volume (30 Days)
- AMLX 789.6K
- ZSPC 72.4K
- Earning Date
- AMLX 05-08-2025
- ZSPC 05-15-2025
- Dividend Yield
- AMLX N/A
- ZSPC N/A
- EPS Growth
- AMLX N/A
- ZSPC N/A
- EPS
- AMLX N/A
- ZSPC 1.03
- Revenue
- AMLX $87,371,000.00
- ZSPC $38,098,000.00
- Revenue This Year
- AMLX N/A
- ZSPC $28.38
- Revenue Next Year
- AMLX N/A
- ZSPC $45.23
- P/E Ratio
- AMLX N/A
- ZSPC $8.55
- Revenue Growth
- AMLX N/A
- ZSPC N/A
- 52 Week Low
- AMLX $1.58
- ZSPC $5.25
- 52 Week High
- AMLX $7.27
- ZSPC $32.69
- Technical
- Relative Strength Index (RSI)
- AMLX 51.34
- ZSPC N/A
- Support Level
- AMLX $3.23
- ZSPC N/A
- Resistance Level
- AMLX $3.83
- ZSPC N/A
- Average True Range (ATR)
- AMLX 0.26
- ZSPC 0.00
- MACD
- AMLX -0.01
- ZSPC 0.00
- Stochastic Oscillator
- AMLX 58.27
- ZSPC 0.00
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About ZSPC ZSPACE INC
ZSPACE Inc is a provider of augmented reality (AR) and virtual reality (VR) educational technology solutions. It focus on both United States K-12 schools and Career & Technical Education (CTE) markets. The company's proprietary hardware and software platform provides the ability to deliver an interactive, stereoscopic three-dimensional (3D) learning experience to users without the need to utilize VR goggles or specialty glasses. The platform serves a broad range of critical educational tools designed for K-12 science, technology, engineering and math (STEM) lessons as well as training skilled trades in areas such as health sciences, automotive engineering/repair, Unity3D software programming and manufacturing. Key revenue is generated from hardware.